Tian et al.(55) have reported that the inhibitor of Lrp5 signaling, Dkk1, is secreted by myeloma cells and have provided evidence to indicate that this is the mediator of myeloma-induced suppression of osteoblast activity. Here, LRP5 is linked to plasma cell myeloma.